COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, 10-day treatment course, ...

BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2024, ...

G&A Expenses: For the quarter ended September 30, 2024, general and administrative (G&A) expenses were $4.4 million, compared to $5.0 million for the same period in 2023. The decrease was primarily ...

Australia: A recent study published in Clinical Infectious Diseases has shown that the current use of integrase strand ...

The pilot open-label randomized clinical trial demonstrated that the use of the drug in addition to protease inhibitor ...

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible Omicron variant.

Netherton syndrome (NS), a rare genetic skin disorder resulting from serine protease inhibitor Kazal type 5 (SPINK5) gene ...

Patients with cancer who receive immune checkpoint inhibitors (ICIs) have more than twice the risk for developing psoriasis compared with those who receive other treatments. Researchers conducted a ...

Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2R3, Canada Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB T6G 2E1, Canada Department ...

Also known as selective COX-2 inhibitors, these medications treat inflammatory pain. Selective COX-2 inhibitors are a type of nonsteroidal anti-inflammatory medication (also known as NSAIDs).

The inhibitors bind to the catalytic zinc ion within the enzyme cavity. Several such derivatives are clinically used inhibitors, such as acetazolamide, methazolamide, ethoxzolamide ...